Your session is about to expire
← Back to Search
Mindfulness-Based Stress Reduction for Chronic Pain (OPTIMUM Trial)
OPTIMUM Trial Summary
This trial will study whether a mindfulness-based stress reduction program can improve function for people with chronic low back pain.
OPTIMUM Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowOPTIMUM Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.OPTIMUM Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My cancer has spread to other parts of my body.I am 18 years old or older.In the past month, I've had worsening pain, unexplained fever, or unexplained weight loss.You have a score of 3 or higher on the PEG scale.If any of your close family members (like parents, siblings, or children) have taken part in the OPTIMUM study, you cannot participate.Criterion: People living in the same house.I have had lower back pain for at least 3 months, with pain on most days in the last 6 months.
- Group 1: Mindfulness Pain Program + Usual PCP Care
- Group 2: Usual PCP Care
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the population size of those enrolled in this clinical trial?
"Affirmative. According to the documentation on clinicaltrials.gov, this medical trial which was originally advertised on May 6th 2021 is currently recruiting patients. Approximately 450 individuals need to be enrolled from 1 distinct healthcare facility."
What aims are being pursued through this experiment?
"The primary endpoint which shall be evaluated over a period of 8 weeks and at baseline is the Pain Interference Group (PEG) score. Secondary outcomes are: Opioid prescription use will be measured through The Current Opioid Misuse Measure® (COMM), Physical function after 12 months assessed with 4-item PROMIS, as well as physical functionality following 8 weeks monitored by 4 item PROMIS."
Are there vacancies available for participants in this clinical trial?
"According to the clinicaltrials.gov, this research is currently open for enrollment; it's inaugural post was on May 6th 2021 and most recently updated July 26th 2022."
Share this study with friends
Copy Link
Messenger